• Insert the full title of the proposed presentation.
• Do not include authors, institutions, city names, trademarks and abbreviations in the title.

• Author(s) Affiliation
• Abstract Authors(s)
• The name of the presenting author must appear first in the list of authors

The body of the text must not exceed 300 words, please make the abstract as an informative as possible, and support your conclusion with data, abstracts texts should be structured to conclude the following sections;

1. Background: Indicate the propose of the study.
2. Method: Describe pertinent experimental procedures.
3. Results: Summarize the result of the research.
4. Conclusions: State the main conclusion, please use standard abbreviations, generic drug names, and place unusual abbreviations or acronyms in parenthesis after first use. DO NOT identify author(s) or institution(s) in the text.

You may choose to submit your abstract under one of the following options to get a chance to compete for the A-PHPBA 2025 awards.

1. Young Investigator Award (for young investigators (up to 35-year-old) to submit abstracts)
   
   • Cash back travel grant: 100 USD/person
     If accepted for mini-oral or short VDO presentation
   • Cash back travel grant: 200 USD/person
     If accepted for Best oral / VDO presentation
2. APHPBA 2025 Presentation Award
   
   • 4 Best ePoster Presentation in 4 categories: Liver, Biliary, Pancreas, Miscellaneous: 300 USD
   • Plenary Oral Presentation and Plenary Video Presentation
     • 1st Prize: 1,000 USD
     • 2nd Prize: 700 USD
     • 3rd Prize: 500 USD
     • 4th – 7th Prize: 300 USD

The A-PHPBA2025 Scientific Committee requests all presenters to disclose their potential conflict(s) of interest at the time of acceptance of presentation (agreement form submission).It is also the responsibility of the presenter to disclose any potential conflict(s) of interest from co-authors pertaining to the presentation on the presentation itself (as may be required).

This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.

A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.

All related potential conflicts of interest must be stated.

This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, being on the board of directors, or being publicly associated with the company or its products. Other areas of real or perceived conflict of interest could include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations.